Status:
UNKNOWN
Radiogenomic and Prognosis Analysis in Glioma
Lead Sponsor:
Asan Medical Center
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate whether MRI can be used to predict genomics and prognosis in glioma. Given the profound prognostic significance of genetic mutations seen in glioma, there have been increas...
Detailed Description
Previous studies have proposed certain imaging characteristics correlating with genetic, molecular and expression patterns. Advanced imaging provides additional clues but no studies have examined its ...
Eligibility Criteria
Inclusion
- Patients suspected of glioma undergoing MRI examination prior to surgery
- MRI including advanced imaging such as cerebral blood volume, apparent diffusion coefficient and amide proton transfer imaging
- Signed informed consent
Exclusion
- Pathologic confirmation as tumors other than glioma
- Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulates, electronic infusion pumps, etc), because such devices may be displaced or malfunction
- Patients who are pregnant or breast feeding; urine pregnancy test will be performed on women of child bearing potential
Key Trial Info
Start Date :
January 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04122521
Start Date
January 12 2020
End Date
February 1 2021
Last Update
February 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea